1294 related articles for article (PubMed ID: 26948435)
1. Guillain-Barré syndrome.
Willison HJ; Jacobs BC; van Doorn PA
Lancet; 2016 Aug; 388(10045):717-27. PubMed ID: 26948435
[TBL] [Abstract][Full Text] [Related]
2. Axonal Guillain-Barré syndrome: concepts and controversies.
Kuwabara S; Yuki N
Lancet Neurol; 2013 Dec; 12(12):1180-8. PubMed ID: 24229616
[TBL] [Abstract][Full Text] [Related]
3. Sensory Guillain-Barré syndrome after Campylobacter jejuni infection.
Rajabally YA; Kass-Hout T; Wilson P; Damian MS
Eur J Neurol; 2007 Mar; 14(3):e11-2. PubMed ID: 17355531
[No Abstract] [Full Text] [Related]
4. Guillain-Barré syndrome: a common neurological entity with myriad manifestations.
Nadkar MY; Bajpai S; Itolikar M
J Assoc Physicians India; 2013 Mar; 61(3):165-6. PubMed ID: 24475677
[No Abstract] [Full Text] [Related]
5. Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody.
Okuda B; Koga M; Katsuta T; Okamoto K; Yuki N
Intern Med; 2002 Oct; 41(10):889-91. PubMed ID: 12413017
[TBL] [Abstract][Full Text] [Related]
6. [Campylobacter jejuni and cytomegalovirus (CMV) infections in patients with the Guillain-Barre syndrome].
Orlikowski D; Quijano-Roy S; Sivadon-Tardy V; Raphael JC; Gaillard JL
Arch Pediatr; 2006 Dec; 13(12):1561-5. PubMed ID: 17030119
[TBL] [Abstract][Full Text] [Related]
7. The immunotherapy of Guillain-Barré syndrome.
Restrepo-Jiménez P; Rodríguez Y; González P; Chang C; Gershwin ME; Anaya JM
Expert Opin Biol Ther; 2018 Jun; 18(6):619-631. PubMed ID: 29681203
[TBL] [Abstract][Full Text] [Related]
8. New concepts of Guillain-Barré syndrome.
Asbury AK
J Child Neurol; 2000 Mar; 15(3):183-91. PubMed ID: 10757475
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
Fokke C; van den Berg B; Drenthen J; Walgaard C; van Doorn PA; Jacobs BC
Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
[TBL] [Abstract][Full Text] [Related]
10. Hyperreflexia in axonal Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis.
Kuwabara S; Nakata M; Sung JY; Mori M; Kato N; Hattori T; Koga M; Yuki N
J Neurol Sci; 2002 Jul; 199(1-2):89-92. PubMed ID: 12084449
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome.
Ansar V; Valadi N
Prim Care; 2015 Jun; 42(2):189-93. PubMed ID: 25979580
[TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré syndrome.
Shahrizaila N; Lehmann HC; Kuwabara S
Lancet; 2021 Mar; 397(10280):1214-1228. PubMed ID: 33647239
[TBL] [Abstract][Full Text] [Related]
13. [Acute inflammatory polyradiculoneuritis (Guillain-Barre syndrome)].
Raphaël JC
Rev Prat; 2001 Dec; 51(19):2119-24. PubMed ID: 11842732
[No Abstract] [Full Text] [Related]
14. Guillain-Barré syndrome: clinical profile and management.
Sudulagunta SR; Sodalagunta MB; Sepehrar M; Khorram H; Bangalore Raja SK; Kothandapani S; Noroozpour Z; Aheta Sham M; Prasad N; Sunny SP; Mohammed MD; Gangadharappa R; Nidsale Sudarshan R
Ger Med Sci; 2015; 13():Doc16. PubMed ID: 26421004
[TBL] [Abstract][Full Text] [Related]
15. Advances in the management of Guillain-Barré syndrome.
Green DM
Curr Neurol Neurosci Rep; 2002 Nov; 2(6):541-8. PubMed ID: 12359110
[TBL] [Abstract][Full Text] [Related]
16. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome.
Tsang RS
Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological, clinical and epidemiological study of Guillain-Barre Syndrome in Hong Kong Chinese.
Hui AC; Chow KM; Tang AS; Fu M; Kay R; Wong KS
J Clin Neurosci; 2005 Feb; 12(2):134-6. PubMed ID: 15749412
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome and variants.
Dimachkie MM; Barohn RJ
Neurol Clin; 2013 May; 31(2):491-510. PubMed ID: 23642721
[TBL] [Abstract][Full Text] [Related]
19. IVIG treatment and prognosis in Guillain-Barré syndrome.
van Doorn PA; Kuitwaard K; Walgaard C; van Koningsveld R; Ruts L; Jacobs BC
J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S74-8. PubMed ID: 20396937
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over intravenous immunoglobulin.
Buzzigoli SB; Genovesi M; Lambelet P; Logi C; Raffaelli S; Cattano D
Anaesth Intensive Care; 2010 Mar; 38(2):387-9. PubMed ID: 20369779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
